Wei-Wei Zhang

Title: Innovations of Wei-Wei Zhang in Immunology

Introduction

Wei-Wei Zhang is a prominent inventor based in San Diego, California. He has made significant contributions to the field of immunology, particularly in the development of methods for generating immune responses to various antigens. With a total of two patents to his name, Zhang's work is paving the way for advancements in cancer treatment and infectious disease response.

Latest Patents

Wei-Wei Zhang's latest patents focus on innovative methods for generating immunity to antigens. These methods involve priming individuals by administering an expression vector that encodes the antigen. The vector includes a transcription unit that encodes a secretable fusion protein, which contains both the antigen and CD40 ligand. This approach enhances the immune response beyond what is achieved through vector administration alone. The methods are particularly useful for generating immune responses against cancer expressing tumor antigens, such as mucins or human papillomavirus tumor antigens, as well as against infectious agents. Additionally, Zhang's patents provide a method for simultaneously producing the expression vector and the fusion protein.

Career Highlights

Wei-Wei Zhang is currently associated with Microvax, LLC, where he continues to innovate in the field of immunology. His work is characterized by a strong focus on enhancing immune responses, which is crucial for developing effective therapies against various diseases.

Collaborations

Zhang has collaborated with notable professionals in his field, including Albert B. Deisseroth and Yucheng Tang. These collaborations have likely contributed to the depth and impact of his research.

Conclusion

Wei-Wei Zhang's contributions to immunology through his innovative patents are significant. His work not only enhances our understanding of immune responses but also holds promise for future therapeutic applications.